Algernon Pharmaceuticals Inc. announces private placement of 200,000 Class A common shares at a issue price of CAD 0.085 per share for gross proceeds of CAD 17,000 on April 3, 2024. The company will issue securities pursuant to exemption provided under Regulation D. The transaction included participation from one non accredited investor.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.125 CAD | +13.64% | +13.64% | +92.31% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+92.31% | 1.98M | |
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |
- Stock Market
- Equities
- AGN Stock
- News Algernon Pharmaceuticals Inc.
- Algernon Pharmaceuticals Inc. announced that it expects to receive CAD 0.017 million in funding